PATENT CLAIM ANALYSIS

Application Number: 16207916
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["544", "070000"]

Abstract:
The invention relates to 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives, their preparation and their use in medicine, particularly in the treatment of pain.

Claim (Index 12):
The compound according to  claim 1 , wherein R 4  means a 3-12-membered cycloalkyl moiety, saturated or unsaturated, unsubstituted, mono- or polysubstituted; wherein the 3-12-membered cycloalkyl moiety is connected through \u2014C 1 -C 6 -alkylene-, linear or branched, saturated or unsaturated, unsubstituted, mono- or polysubstituted.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 98.0
- Lexical Diversity: 1.13043
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11994001', '12700857', '12699451', '15125615', '12604691']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7955891020119361
- 35 USC 102 Novelty (BERT): 0.5419911776069659
- Combined Prediction Score: 0.7702293095714392
- Mean Citation Score: 376.134266
- Max Citation Score: 388.24194
- Similarity Product: 255.8140577474713

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test